The Effect of Leukemia Vaccine Treatment on Cellular Immune Function of Tumor Burden Mice

赵万红,何爱丽,张王刚,王一理,耿宜萍,田玮,宋长琐

DOI: https://doi.org/10.3872/j.issn.1007-385x.2001.04.008

2001-01-01

Chinese Journal of Cancer

Abstract:Objective: To evaluate the efficacy of the active specific immunotherapy with leukemia vaccine in the malignant hematopoietic diseases. Methods: We established the erythroleukemia burden mice and prepared three types of leukemia vaccine which were administered on the mice respectively. The MTT colorimetric method was adopted 2 and 4 weeks later to measure the cytotoxicity of Mφ and CTL derived from the mice accepted immunotherpay, and compared with control group.Results: With the growth of erythroleulemia cells in the mice, the cellular immunity was seriously depressed, and the inhibition of specific cellular immunity was later than non-specific cellular immunity. The administration of tumor vaccine prepared from inactivated tumor cells, IFA and cytokines(rGM-CSF, rIL-2 and rIL-6), promote the cellular immunity of tumor burden mice, especially the specific cellular immunity more efficiently than tumor vaccine made from inactivated tumor cells and IFA, but the vaccine composed of inactive tumor cells themselves alone has no effect.Conclusion: The tumor vaccine simply prepared with inactive tumor cells, IFA and cytokines(rGM-CSF, rIL-2 and rIL-6) provides a promising future in the active specific immunotherapy against hematopoietic tumor.